What is pulmonary fibrosis and what causes it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pulmonary Fibrosis?

Pulmonary fibrosis is a lung disease where your lungs become scarred and stiff, making it progressively harder to breathe. 1, 2 Think of it like your lungs developing thick scar tissue that prevents them from expanding and contracting normally, similar to how a rubber band loses its stretch when it gets old and damaged. 1

How Your Lungs Are Affected

  • Your lungs normally have tiny air sacs (like microscopic balloons) that fill with air when you breathe 1
  • In pulmonary fibrosis, scar tissue builds up around these air sacs, making the lung tissue thick and stiff 1, 3
  • This scarring prevents oxygen from passing easily into your bloodstream, causing shortness of breath, especially during physical activity 2, 4
  • The disease is progressive, meaning it typically gets worse over time 1, 2

What Causes Pulmonary Fibrosis?

The causes fall into several categories:

Unknown Causes (Idiopathic)

  • In many cases, doctors cannot identify a specific cause—this is called "idiopathic pulmonary fibrosis" or IPF 1, 2
  • IPF primarily affects people over age 60, with most patients in their 60s and 70s 1, 2
  • Men are affected more often than women 1, 2

Environmental and Occupational Exposures

  • Cigarette smoking is a significant risk factor, increasing your risk 1.6 to 2.9 times 1
  • Metal dust and wood dust exposure (especially steel, brass, lead, and pine wood) from years of workplace exposure 1
  • Asbestos, silica, and other mineral dusts from construction, mining, or manufacturing work 1, 5
  • Chronic exposure to mold, bird droppings, or agricultural dust (called hypersensitivity pneumonitis) 1

Medications

  • Certain chemotherapy drugs like bleomycin and cyclophosphamide 5
  • Heart medications like amiodarone 5
  • Antibiotics like nitrofurantoin 5
  • Other drugs including gold, penicillamine, and procainamide 5

Medical Conditions

  • Autoimmune diseases such as rheumatoid arthritis, systemic sclerosis (scleroderma), and lupus 1, 5
  • Chronic acid reflux (gastroesophageal reflux) with repeated aspiration of stomach contents into the lungs 1, 2

Infections

  • Possible association with viral infections including Epstein-Barr virus, hepatitis C, and cytomegalovirus, though this remains uncertain 1, 2

Genetic Factors

  • About 30% of patients have genetic factors that increase their risk 2
  • Some families have multiple members affected (familial pulmonary fibrosis) 1
  • Genetic mutations affecting telomeres (the protective caps on chromosomes) are associated with premature aging of lung cells 1

Common Symptoms

  • Progressive shortness of breath, especially with physical activity 2, 4
  • Persistent dry cough that doesn't respond to typical cough medicines 2
  • Crackling sounds in the lungs (like Velcro being pulled apart) that doctors hear with a stethoscope 2
  • Clubbing of fingertips (fingertips become rounded and enlarged) in less than half of patients 2, 3
  • Fatigue and general weakness as the disease progresses 4

Prognosis

  • Without treatment, the median survival is 2-4 years after diagnosis 2, 4, 3
  • The disease is progressive and currently cannot be cured, though medications can slow its progression 2, 4
  • Lung transplantation is the only treatment that can improve survival for eligible patients 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Idiopathic Pulmonary Fibrosis (IPF): Definition, Characteristics, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Idiopathic pulmonary fibrosis.

Orphanet journal of rare diseases, 2008

Research

Idiopathic pulmonary fibrosis.

Presse medicale (Paris, France : 1983), 2023

Research

Drug-induced pulmonary fibrosis.

Saudi medical journal, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.